alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
1 In The 

### Court of Appeals Ninth District of Texas at Beaumont

__________________ N O . 09
- 22
- 00095
- CV

__________________
IN THE INTEREST OF J. E.

__________________________________________________________________ On Appeal from the County Court at Law No. 3 Mo ntgomery County, Texas Trial Cause No. 21
- 09
- 13473
- CV

__________________________________________________________________ MEMORANDUM OPINION On March 3, 2022, the trial court signed a final order terminating the parent

child relationship between T.H. and J.E. and between J.E. and J.E. On March 23, 2022, J.E. filed a motion for new trial. On May 4, 2022, the trial court signed an order granting J.E.’s motion for new trial. On May 16, 2022, we abated the appeal and remanded the case to the trial co urt and warn ed that unless we received a supplemental clerk’s record containing a final, appealable order or judgment by June 24, 202 2, the appeal would be dismissed for want of jurisdictio n. To date, we have2 not received a supplemental clerk’s record. No party requested additional time to obtain a final judgment or severance order. This Court lacks jurisdiction over interlocutory appea ls of parental termination decrees . See In re J.M.E. , No. 04

- 21

- 00317

- CV, 2021 WL 4875528, at *1 (Tex. App.

— San Antonio Oct. 20, 2021, no pet.). Accordingly, we dismiss the appeal for lack of jurisdiction. See Tex. R. App. P. 42.3(a), 43.2(f).
APPEAL DISMISSED.
PER CURIAM

Submitted on July 27, 2022 Opinion Delivered July 28, 2022 Before Golemon, C.J., Kreger and Horton, JJ.
Exhibit 31.1
                                  CERTIFICATION

I, Thomas E. Mills, certify that:

1.   I have reviewed this annual report on Form 10-KSB of Scarab Systems, Inc.;

2.   Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

3.   Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;

4.   I am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
registrant and we have:

     a)   designed such disclosure controls and procedures to ensure that
          material information relating to the registrant, including its
          consolidated subsidiaries, is made known to us by others within those
          entities, particularly during the period in which this annual report
          is being prepared;

     b)   evaluated the effectiveness of the registrant's disclosure controls
          and procedures as of a date within 90 days prior to the filing date of
          this annual report (the "Evaluation Date"); and

     c)   presented in this annual report our conclusions about the
          effectiveness of the disclosure controls and procedures based on our
          evaluation as of the Evaluation Date;

5.   I have disclosed, based on my most recent evaluation, to the registrant's
auditors and the audit committee of registrant's board of directors (or persons
performing the equivalent
function):

     a)   all significant deficiencies in the design or operation of internal
          controls which could adversely affect the registrant's ability to
          record, process, summarize and report financial data and have
          identified for the registrant's auditors any material weaknesses in
          internal controls; and

     b)   any fraud, whether or not material, that involves management or other
          employees who have a significant role in the registrant's internal
          controls; and

6.   I have indicated in this annual report whether there were significant
changes in internal controls or in other factors that could significantly affect
internal controls subsequent to the date of our most recent evaluation,
including any corrective actions with regard to significant deficiencies and
material weaknesses.

April  28 , 2004

By /s/ Thomas E. Mills
Thomas E. Mills
Chief Executive Officer, Chief Financial Officer and President
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THE FINANCIAL DATA SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM [Identify specific financial statements] AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                             363
<SECURITIES>                                         0
<RECEIVABLES>                                    6,283
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 8,526
<PP&E>                                          25,846
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  42,421
<CURRENT-LIABILITIES>                            4,394
<BONDS>                                         35,180
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            35
<OTHER-SE>                                       2,194
<TOTAL-LIABILITY-AND-EQUITY>                    42,421
<SALES>                                         21,945
<TOTAL-REVENUES>                                21,945
<CGS>                                                0
<TOTAL-COSTS>                                   22,321
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               2,661
<INCOME-PRETAX>                                (2,950)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,950)
<EPS-PRIMARY>                                   (0.87)
<EPS-DILUTED>                                        0
        

</TABLE>
EXHIBIT 10.23 FIRST AMENDMENT TO DISTRIBUTION AGREEMENT This First Amendment to Distribution Agreement (this Amendment) is made and entered into the 24th day of October, 2003, by and between Dexterity Surgical, Inc. (Dexterity) and Pilling Weck Incorporated, successor to Weck Closure Systems, LLC (Distributor). Dexterity and Distributor are hereinafter sometimes referred to as the Parties. W I T N E S S E T H: WHEREAS, the Parties previously entered into a Distribution Agreement dated as of June 5, 2001 (the Agreement); and WHEREAS, the Parties desire to amend the Agreement in order to extend the term of the Agreement, to provide Dexterity advances against future shipments, and certain other modifications, as further set forth herein. NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein, and intending to be legally bound, the Parties hereto agree as follows: 1.     Unless elsewhere expressly defined in this Amendment, all capitalized terms used herein shall have the definitions given to such terms in the Agreement. 2.     Distributor has made previous advance payments to Dexterity. The outstanding advanced amount of $123,000 (First Advance) by Distributor will be offset against Distributors purchase orders Nos. P17873, P17874, P17875 and P17876. 3.     Distributor will advance $150,000 (Second Advance) to Distributor promptly after execution of this Amendment by the Parties. Dexterity will offset the Second Advance against Distributors purchase orders issued during the fourth calendar quarter of 2003 and all other future purchase orders issued by Distributor until the full amount of the Second Advance has been offset and repaid to Distributor. 4.     Section 3 of the Agreement is hereby deleted in its entirety and shall now read: The initial term of this Agreement shall expire on the date that Dexterity shall have repaid the First Advance and the Second Advance to Distributor through offsets against Distributors purchase orders; provided however that in no event shall this Agreement expire earlier than June 30, 2004. 5.     New Section 6.8 is hereby inserted into the Agreement, which new section shall read as follows:     6.8 Simultaneously with Dexteritys cost reductions from Apogee for the Products, Dexterity will pass on to Distributor 100% of Apogees cost reductions in the form of lower transfer pricing for the Products. 6.            During the period of the extension of the Agreement as provided for herein, the Parties agree to negotiate a new distribution agreement, which includes a new pricing structure utilizing anticipated Apogee cost reductions. 7.            Except as amended hereby, the terms of the Amendment shall continue in full force and effect in accordance with their terms. IN WITNESS WHEREOF, the parties have caused this Amendment to be duly executed and delivered by their respective duly authorized officers as of the date first above written. DEXTERITY SURGICAL, INC.By:/s/ Randall K. BoatrightName: Randall K. BoatrightTitle: Executive Vice President and CFOPILLING WECK INCORPORATEDBy:/s/ Chris TihanskyName: Chris TihanskyTitle: Vice President Surgical
**EXHIBIT 23.1**

 

**CONSENT OF INDEPENDENT ACCOUNTANTS**

 

We hereby consent to the incorporation byreference in the Registration Statements on Form S-3 (No. 333-64693 and 333-75581) and Form S-8 (Nos. 333-88592, 333-94306, 333-02378, 333-28405, 333-67031, 333-76923, 333-84687, 333-95721, 333-56498, and 333-61022) of Legato Systems, Inc ofour report dated February 4, 2003, relating to the consolidated financial statements, which appears in this Form 10-K. 

 

/s/    PRICEWATERHOUSECOOPERS LLP 

 

San Jose, California 

February 28, 2003
[Federal Register Volume 82, Number 190 (Tuesday, October 3, 2017)]
[Notices]
[Page 46085]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-21138]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel NIAID Peer Review Meeting.
    Date: October 26-27, 2017.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892, (Telephone Conference Call).
    Contact Person: Susana Mendez, DVM, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, Room 3G53B, National Institutes of Health, NIAID, 5601 
Fishers Lane Dr., MSC 9823, Bethesda, MD 20892-9823, (240) 669-5077, 
<a href="/cdn-cgi/l/email-protection#e588808b81809f96a58b8c848c81cb8b8c8dcb828a93"><span class="__cf_email__" data-cfemail="80ede5eee4e5faf3c0eee9e1e9e4aeeee9e8aee7eff6">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 27, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-21138 Filed 10-2-17; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR U.S. LONG DISTANCE CORP. AND
SUBSIDIARIES AS OF AND FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 1996 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-1996
<PERIOD-START>                             OCT-01-1995
<PERIOD-END>                               SEP-30-1996
<CASH>                                           8,842
<SECURITIES>                                         0
<RECEIVABLES>                                   38,386
<ALLOWANCES>                                     2,519
<INVENTORY>                                          0
<CURRENT-ASSETS>                                50,711
<PP&E>                                          60,110
<DEPRECIATION>                                  30,251
<TOTAL-ASSETS>                                  99,244
<CURRENT-LIABILITIES>                           30,638
<BONDS>                                         10,289
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           153
<OTHER-SE>                                      58,112
<TOTAL-LIABILITY-AND-EQUITY>                    99,244
<SALES>                                              0
<TOTAL-REVENUES>                               180,346
<CGS>                                                0
<TOTAL-COSTS>                                  118,493
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                 8,388
<INTEREST-EXPENSE>                               1,356
<INCOME-PRETAX>                               (17,104)
<INCOME-TAX>                                     3,350
<INCOME-CONTINUING>                           (13,754)
<DISCONTINUED>                                  15,161
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,407
<EPS-PRIMARY>                                      .09
<EPS-DILUTED>                                      .09
        

</TABLE>
Exhibit 32.1





Certification of CEO and CFO

Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002







In connection with the Annual Report on Form 10-KSB of National Tax Credit Investors II (the "Partnership"), for the fiscal year ended December 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Martha L. Long, as the equivalent of the chief executive officer of the Partnership, and Stephen B. Waters, as the equivalent of the chief financial officer of the Partnership, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:



(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Partnership.



| |                        
| | -----------------------
| | /s/Martha L. Long      
| | Name: Martha L. Long   
| | Date: April 14, 2008   
| |                        
| | /s/Stephen B. Waters   
| | Name: Stephen B. Waters
| | Date: April 14, 2008   



This certification is furnished with this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Partnership for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>                         <C>
<PERIOD-TYPE>                   12-MOS                      12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999                 DEC-31-1998
<PERIOD-START>                             JAN-01-1999                 JAN-01-1998
<PERIOD-END>                               DEC-31-1999                 DEC-31-1998
<CASH>                                          92,000                     173,000
<SECURITIES>                                         0                           0
<RECEIVABLES>                                  705,000                     636,000
<ALLOWANCES>                                   116,000                      13,000
<INVENTORY>                                          0                           0
<CURRENT-ASSETS>                               889,000                   1,687,000
<PP&E>                                       2,187,000                   2,139,000
<DEPRECIATION>                              (2,054,000)                 (1,927,000)
<TOTAL-ASSETS>                               1,056,000                   2,081,000
<CURRENT-LIABILITIES>                        2,459,000                     734,000
<BONDS>                                              0                           0
<PREFERRED-MANDATORY>                                0                           0
<PREFERRED>                                          0                           0
<COMMON>                                        68,000                      34,000
<OTHER-SE>                                  (1,471,000)                  1,313,000
<TOTAL-LIABILITY-AND-EQUITY>                 1,056,000                   2,081,000
<SALES>                                      4,044,000                   3,681,000
<TOTAL-REVENUES>                             4,044,000                   3,681,000
<CGS>                                        2,969,000                   2,730,000
<TOTAL-COSTS>                                4,414,000                   4,795,000
<OTHER-EXPENSES>                               (92,000)                    (13,000)
<LOSS-PROVISION>                                 1,000                      24,000
<INTEREST-EXPENSE>                              87,000                      11,000
<INCOME-PRETAX>                               (462,000)                 (1,101,000)
<INCOME-TAX>                                         0                           0
<INCOME-CONTINUING>                           (462,000)                 (1,101,000)
<DISCONTINUED>                              (2,333,000)                   (295,000)
<EXTRAORDINARY>                                      0                           0
<CHANGES>                                            0                           0
<NET-INCOME>                                (2,795,000)                 (1,396,000)
<EPS-BASIC>                                       (.42)                       (.57)
<EPS-DILUTED>                                     (.42)                       (.57)


</TABLE>
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3247 Introduced in House (IH)]

112th CONGRESS
  1st Session
                                H. R. 3247

 To designate the facility of the United States Postal Service located 
  at 1100 Town and Country Commons in Chesterfield, Missouri, as the 
      ``Lance Corporal Matthew P. Pathenos Post Office Building''.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            October 24, 2011

   Mr. Akin (for himself, Mr. Clay, Mr. Carnahan, Mrs. Hartzler, Mr. 
   Cleaver, Mr. Graves of Missouri, Mr. Long, Mrs. Emerson, and Mr. 
 Luetkemeyer) introduced the following bill; which was referred to the 
              Committee on Oversight and Government Reform

_______________________________________________________________________

                                 A BILL

 
 To designate the facility of the United States Postal Service located 
  at 1100 Town and Country Commons in Chesterfield, Missouri, as the 
      ``Lance Corporal Matthew P. Pathenos Post Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. LANCE CORPORAL MATTHEW P. PATHENOS POST OFFICE BUILDING.

    (a) Designation.--The facility of the United States Postal Service 
located at 1100 Town and Country Commons in Chesterfield, Missouri, 
shall be known and designated as the ``Lance Corporal Matthew P. 
Pathenos Post Office Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Lance 
Corporal Matthew P. Pathenos Post Office Building''.
                                 <all>
```
## COURT OF APPEALS

SECOND DISTRICT OF TEXAS

FORT WORTH

NO. 02

- 13

- 00045

- CR

Adan Martinez

v.

The State of Texas §

§

§

§

§ From t he 371st District Court

o f Tarrant County ( 1219208D )

March 14, 2013

P er C uriam

(nfp)



### JUDGMENT

This court has considered the record on appeal in this case and holds that

the appeal should be dismissed. It is order ed that the appeal is dismissed for

wan t of jurisdiction

.

SECOND DISTRICT COURT OF APPEALS

PER CURIAM2 

## COURT OF APPEALS

SECOND DISTRICT OF TEXAS

FORT WORTH

NO. 02

- 13

- 00045

- CR

ADAN MARTINEZ APPELLANT

V.

THE STATE OF TEXAS STATE

----------

FROM THE 371ST DISTRICT COURT OF TARRANT COUNTY

----------



### MEMORANDUM OPINION 1

----------

Adan Martinez attempts to appeal from his conviction and fif t een

- year

sentence for aggravated kidnapping

.

The trial court sentenced appellant on October 17, 2011. Because

a ppellant did not file a motion for new trial , his notice of appeal was due

November 16, 2011

. Se e Tex. R. App. P. 26.2(a)(1 ). Appellant did not file a

notice of appeal until February 1, 2013 (which he mailed on January 28, 2013).

1 See Tex. R. App. P. 47.4.3

We have received no response to our February 5, 2013 inquiry regarding

jurisdiction.

Because appellant did not timely in voke the jurisdiction of this court, 2 we

dismiss th e appeal for want of jurisdiction. See Tex. R. App. P. 43.2(f); Olivo v.

State , 918 S.W.2d 519, 522

– 23 (Tex. Crim. App. 1996).

PER CURIAM

PANEL: LIVINGSTON, C.J.; DAUPHINOT and GARDNER, JJ.

DO NOT PUB LISH

Tex. R. App

. P. 47.2(b )

DELIVERED: March 14, 2013

2 Even if appellant’s notice of appeal had been timely, the trial court’s

certification of his right to appeal correctly states that this “is a plea

- bargain case,

and the de f endant has NO right of appeal.” See Tex. R. App. P. 25.2(a)(2), (d).